The PPP2R5C mRNA and protein expression levels in treated CML cells were analyzed by quantitative real-time PCR and Western blotting, and in vitro cell proliferation was assayed with the cell counting kit-8 method. Here, PPP2R5C is linked to chronic myelogenous leukemia, BCR-ABL1 positive.